NW Roselle
- Generic Name
- NW Roselle
NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial
Phase 3
Not yet recruiting
- Conditions
- Essential Hypertension
- Interventions
- First Posted Date
- 2023-11-21
- Last Posted Date
- 2023-11-21
- Lead Sponsor
- Natural Wellness Egypt
- Target Recruit Count
- 286
- Registration Number
- NCT06141200
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath